Literature DB >> 18793143

Regulation of ER-associated degradation via p97/VCP-interacting motif.

Petek Ballar1, Shengyun Fang.   

Abstract

p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD [ER (endoplasmic reticulum)-associated degradation]. gp78, an ERAD ubiquitin ligase, is one of the p97/VCP recruitment proteins localized to the ER membrane. A newly identified VIM (p97/VCP-interacting motif) in gp78 has brought about novel insights into mechanisms of ERAD, such as the presence of a p97/VCP-dependent but Ufd1-independent retrotranslocation during gp78-mediated ERAD. Additionally, SVIP (small p97/VCP-interacting protein), which contains a VIM in its N-terminal region, negatively regulates ERAD by uncoupling p97/VCP and Derlin1 from gp78. Thus SVIP may protect cells from damage by extravagant ERAD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793143     DOI: 10.1042/BST0360818

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  11 in total

Review 1.  HECT and RING finger families of E3 ubiquitin ligases at a glance.

Authors:  Meredith B Metzger; Ventzislava A Hristova; Allan M Weissman
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

2.  Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol.

Authors:  Poulomi Acharya; Mingxiang Liao; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

3.  Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway.

Authors:  Eric A Fisher; Neeraj A Khanna; Roger S McLeod
Journal:  J Lipid Res       Date:  2011-03-18       Impact factor: 5.922

4.  The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).

Authors:  Linda Sasset; Gianluca Petris; Francesca Cesaratto; Oscar R Burrone
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

5.  Structure and expression of a novel compact myelin protein - small VCP-interacting protein (SVIP).

Authors:  Jiawen Wu; Dungeng Peng; Markus Voehler; Charles R Sanders; Jun Li
Journal:  Biochem Biophys Res Commun       Date:  2013-09-18       Impact factor: 3.575

6.  Epigenetic loss of the endoplasmic reticulum-associated degradation inhibitor SVIP induces cancer cell metabolic reprogramming.

Authors:  Pere Llinàs-Arias; Margalida Rosselló-Tortella; Paula López-Serra; Montserrat Pérez-Salvia; Fernando Setién; Silvia Marin; Juan P Muñoz; Alexandra Junza; Jordi Capellades; María E Calleja-Cervantes; Humberto J Ferreira; Manuel Castro de Moura; Marina Srbic; Anna Martínez-Cardús; Carolina de la Torre; Alberto Villanueva; Marta Cascante; Oscar Yanes; Antonio Zorzano; Catia Moutinho; Manel Esteller
Journal:  JCI Insight       Date:  2019-03-07

7.  UBXN2A regulates nicotinic receptor degradation by modulating the E3 ligase activity of CHIP.

Authors:  Yanfen Teng; Khosrow Rezvani; Mariella De Biasi
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

8.  VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.

Authors:  Emilie Tresse; Florian A Salomons; Jouni Vesa; Laura C Bott; Virginia Kimonis; Tso-Pang Yao; Nico P Dantuma; J Paul Taylor
Journal:  Autophagy       Date:  2010-02-22       Impact factor: 16.016

9.  SVIP regulates Z variant alpha-1 antitrypsin retro-translocation by inhibiting ubiquitin ligase gp78.

Authors:  Nazli Khodayari; Rejean Liqun Wang; George Marek; Karina Krotova; Mariana Kirst; Chen Liu; Farshid Rouhani; Mark Brantly
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

10.  Molecular insights in the pathogenesis of classical Ehlers-Danlos syndrome from transcriptome-wide expression profiling of patients' skin fibroblasts.

Authors:  Nicola Chiarelli; Giulia Carini; Nicoletta Zoppi; Marco Ritelli; Marina Colombi
Journal:  PLoS One       Date:  2019-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.